AntrePoint

AntrePoint

$NNDM has been following an inverse head and shoulders pattern since February. It has now broken out of the pattern and managed to stay above the neckline after retesting it yesterday. I expect bullish price movement towards a $17 price target as long as Nano Dimension continues trading above the neckline. Congratulation to everyone who bought the single digit...

AntrePoint

Throughout the last one month, I noticed that US10Y has been trading within an ascending broadening wedge chart pattern, and has been respecting the two diverging bullish lines that form its dynamic support and resistance extremely well. After bouncing off the dynamic support of the ascending broadening wedge, US10Y is now halfway through its growth towards the...

AntrePoint

After a false breakout due to a correction in the broader market, $CLOV has re-entered the falling channel it has broken out of and closed within it. From this area, I expect growth towards the resistance zone around $9.92 to $10.00. However, do note that this zone of resistance that we are heading for is a very strong area of resistance. In this area, we see...

AntrePoint

Since the market started selling-off late February due to disturbance in the bond market, the movements of $CLOV has since been mirroring the direction of the overall market relatively tightly. With the closing of the market earlier today after a considerably sideway and mixed trading day, S&P 500 rose by 0.60%, NASDAQ fell by 0.04%, while Dow Jones Industrial...

AntrePoint

Tuesday's 3-year notes auction, Wednesday's 10-year notes auction, and Thursday's 30-year bond sale are 3 of the most closely watched auction that will be happening this week due to the recent focus on bond yields which have been a key driver of stock movements. We saw that on Tuesday, the $58 billion auction in 3-year notes was well-received, attracting demand...

AntrePoint

Amid rising concerns on inflation, today's release of Consumer Price Index (CPI) data for February is among the most anticipated event of the month. The CPI acts as a gauge for inflation, where it measures the average change in prices over time that consumers pay for a basket of goods and services. The CPI data vs Analysts' estimates is as follows, CPI: 0.4% vs...

AntrePoint

After experiencing a sharp spike in the 10-year Treasury yield last month due to an unexpectedly weak demand of a US$62 billion 7-year notes auction, today marked the start of a crucial bond auction week that will test the condition of the bond market. This week's schedule is as follows, Tuesday: $58 billion auction in 3-year notes Wednesday: $38 billion auction...

AntrePoint

The movement of $CLOV continues to mirror the condition of the overall market. Today, the tech-led sell-off took a pause, with S&P 500 rising by 1.95% and NASDAQ Composite rising by 1.55%. Similarly, Clover Health ended higher by 7.54%, closing above the previous day's close. Going into next week, I expect $CLOV performance to continue reflecting the overall...

AntrePoint

Aggravated by Jerome Powell's speech at the Wall Street Journal Jobs Summit, the tech-led sell-off continues, causing the Dow Jones Industrial Average to fall by 1.11%, S&P 500 by 1.34%, and Nasdaq Composite by 2.11%. On that note, the 10-year Treasury yield also popped to 1.541% during Jerome Powell's speech, later closing at that level for the day. But how,...

AntrePoint

The bearish channel has broken to the downside and we are now in an unchartered territory. Within this unchartered territory, I expect every $0.50 to be a new support (i.e. $8.50, $8.00, $7.50, $7.00, and so on). As of the time that I am writing this post, we have broken the $8.50 support and found a $8.03 low. It will be difficult to predict where we will find a...

AntrePoint

From 2019 to 2020, $CLOV posted a total revenue growth from $462.3M to $672.9M, net premium revenue growth from $456.9M to $665.7M, decrease in net loss from -$363.7M to -$91.6M, and a decrease in adjusted EBITDA loss from -$175.5M to -$74.4M, among others. $CLOV also saw a 36.3% increase in membership and a 43.2% year-over-year increase in lives under Clover...

AntrePoint

$CLOV continues to move within the symmetrical triangle while being encapsulated by a bearish channel. As we approach the end of the symmetrical triangle, I am expecting a breakout to by next week, as early as Monday. I believe the upcoming earnings on 03/01/2021's post-market to be a major catalyst to which direction the breakout will be. Bear Case: In the...

AntrePoint

The market was extremely bloody last night, where we saw $TQQQ trading at highs of $98.07 at one point and subsequently closing at $87.90. I believe this can be attributed to the rising bond yields trend we are currently witnessing, particularly in the 5 year and 10 year treasury yield. Between the start of February 2021 to February 24th, the 5 year treasury...

AntrePoint Updated 

GameStop is back from the ashes. For how long this time? We do not know. But one thing for sure is - You need to have a game plan tomorrow. Back in January, we saw how $GME can bring emotionally-prepared people who know what they are doing to the literal moon. But we also saw how people who FOMO in their life savings blindly and emotionally without a plan had...

AntrePoint

Nano Dimension is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME), where its machines serve cross-industry needs by depositing proprietary consumable conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical...

AntrePoint Updated 

The market has been a bloodbath the last 4 trading days. We saw share price across the board easily correcting 5%, 10%, 12%, and even 15% each day. However, I believe that the correction is not over yet. We will likely re-test the support of the bullish channel at around $84.32 to $87.27. This is a very healthy correction that is long overdue. Use this...

AntrePoint

After smashing through our $87.27 price target, $TQQQ rejected violently back to the $96 level. This could be a sign that the worse of the correction could be over for the time being. However, I still wouldn't be too optimistic about it yet as we could still see a second and third re-test of the bullish channel's support level. As such, keep the movement of $TQQQ...

AntrePoint Updated 

Coming in as the 13th largest position in the ARKG ETF with a 2.68% weight (as of 02/18/2021), CRISPR Therapeutics AG is arguably one of Cathie Wood's favorite play in this space. Since hitting the Highs of $220.20 on 01/15/2021, $CRSP has been on a steady decline to the lows of $142.15, forming a clear Head & Shoulder pattern on the daily chart in the process....